Biotech & Bioprocessing

The complexity of molecular transformations in pharmaceutical synthesis demands enzymes that maintain high selectivity without sacrificing the speed of the chemical reaction. These biological catalysts are the foundation of many life-sustaining processes, yet their natural forms are rarely suited

By mimicking the natural bone extracellular matrix, these composite scaffolds address the physiological limitations of existing synthetic materials used in orthopedic surgery. The global healthcare landscape is currently navigating a quiet but profound crisis as bone-related injuries and

In performance tests involving over four thousand unknown genomes, PathogenFinder2 demonstrated superior predictive accuracy compared to existing genomic surveillance tools. This breakthrough comes at a critical juncture in 2026, as the global community faces an increasingly complex landscape of

Aspen Neuroscience’s sasineprocel starts with cells collected from a patient’s skin and aims to rebuild a population of neurons lost in Parkinson’s disease. To advance clinical testing, the company has raised $140.6 million through an initial public offering. The program now has to answer a central

Public panic during the Irkutsk incident was exacerbated by the circulation of sensationalist literature that often conflates legitimate scientific research with offensive biological warfare. The death of a seasoned researcher at the Irkutsk Anti-Plague Research Institute in October 2026 has become

Faster-growing yeast cells in continuous culture produce enzymes with higher specific activity, suggesting that growth rate directly influences the quality of the final protein product. This discovery marks a pivotal shift in how bioengineers approach the metabolic trade-off between cellular growth